Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2026-05-08 @ 10:06 PM
Study NCT ID:
NCT02356458
Status:
TERMINATED
Last Update Posted:
2022-03-11
First Post:
2015-02-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma
Sponsor:
Swiss Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SAKK 36/13
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |